← Back to Patent Explorer
US4539333A Expired / Lapsed US ⏱️ 0.0 years remaining

Prostacyclin, methods of using and method of making

Assignee: SmithKline Beecham Corp
•
Filing: 1977-05-10
•
Granted: 1985-09-03
•
Expires: 1997-05-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Prostacyclin, its salts, biosynthesis and synthesis thereof, pharmaceutical formulations containing them, and their use in medicine.

Inventors

  • 👤 Salvador Moncada

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 21:55
CPC Classifications
C; C07; C07D; C07D307/00; C07D307/77; C07D307/93; C07D307/935; C07D307/937

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 7 words
Prostacyclin substantially free from other biological material.
Claim 2
Dependent Claim 7 words
Prostacyclin substantially free from other biological material.
Claim 3
Independent Claim 23 words
The method of treating thrombosis in a mammal which comprises administering an effective antithrombotic portion of prostacyclin to said mammal in need thereof.
Claim 4
Independent Claim 23 words
The method of treating thrombosis in a mammal which comprises administering an effective antithrombotic portion of prostacyclin to said mammal in need thereof.
Claim 5
Independent Claim 25 words
The method of inhibiting the aggregation of blood platelets in a mammal which comprises administering an effective platelet antiaggregation amount of prostacyclin to said mammal.
Claim 6
Independent Claim 25 words
The method of inhibiting the aggregation of blood platelets in a mammal which comprises administering an effective platelet antiaggregation amount of prostacyclin to said mammal.
Claim 7
Independent Claim 24 words
A method of preventing thrombosis in a mammal in need thereof which comprises administering an effective thrombosis prevention amount of prostacyclin to said mammal.
Claim 8
Independent Claim 24 words
A method of preventing thrombosis in a mammal in need thereof which comprises administering an effective thrombosis prevention amount of prostacyclin to said mammal.
Claim 9
Independent Claim 28 words
A method for the prevention or treatment of gastric lessions in a mammal comprising the administration of a non-toxic prevention or treatment amount of prostacylin to said mammal.
Claim 10
Independent Claim 28 words
A method for the prevention or treatment of gastric lessions in a mammal comprising the administration of a non-toxic prevention or treatment amount of prostacylin to said mammal.
Claim 11
Independent Claim 24 words
A method for the treatment of a wound in a mammal which comprises administering to said mammal a non-toxic wound treatment amount of prostacylin.
Claim 12
Independent Claim 24 words
A method for the treatment of a wound in a mammal which comprises administering to said mammal a non-toxic wound treatment amount of prostacylin.
Claim 13
Independent Claim 30 words
A method for producing a vasodilatory action in the blood vessels of a mammal in need thereof comprising the administration of an effective vasodilatory amount of prostacyclin to said mammal.
Claim 14
Independent Claim 30 words
A method for producing a vasodilatory action in the blood vessels of a mammal in need thereof comprising the administration of an effective vasodilatory amount of prostacyclin to said mammal.
Claim 15
Independent Claim 19 words
The method of preparing (5-Z)-5,6-Didehydro-9-deoxy-6,9α-epoxyprostaglandin F 1 α which comprises incubating microsomes of mammalian tissue with a prostaglandin endoperoxide.
Claim 16
Independent Claim 19 words
The method of preparing (5-Z)-5,6-Didehydro-9-deoxy-6,9α-epoxyprostaglandin F 1 α which comprises incubating microsomes of mammalian tissue with a prostaglandin endoperoxide.
Claim 17
Dependent Claim 23 words
The method of claim 8 in which the microsomes are aortic microsomes and the prostaglandin endoperoxides are PGG 2 or PGH 2 .

References Cited (Backward Citations)

US4158667A Cited
US4338325A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-09-02 1989-03-04 1989-09-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-09-02 1993-03-04 1993-09-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-09-02 1997-03-04 1997-09-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag